sunday 23 sEpTEMbEr - ehmtic 2012

EHMTIC20I2
European Headache and Migraine Trust International Congress
P187 Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine
Ahmed, F.; Khalil, M.; quarshie, V.
Hull and East Yorkshire Hospitals NHS Trust, United Kingdom
P188 OnabotulinumtoxinA injections for the pain relief and long-term symptom control in a patient with hemiplegic
migraine: Case study
Dhawan, P.; Dhawan, P.
Dhawan Medical Corporation, Canada
P189 Ornithine in chronic migraine therapy and allodynia pattern: comparison with dopaminergic activation
Nicolodi, M.; Nicolodi, M.
Foundation Prevention and Therapy Primary Pain, Italy
P190 MAP0004 provided consistent migraine pain relief even after repeated administration
Kori, S.; Lu, B.; Connors, E.; Li, X.; Kellerman, D.
MAP Pharmaceuticals, United States
P191 Frovatriptan vs other triptans in the treatment of menstrual migraine: pooled analysis of three double-blind,
randomized, cross-over studies
Allais, G. 1 ; Tullo, V. 2 ; Omboni, S. 3 ; Benedetto, C. 1 ; Sances, G. 4 ; Zava, D. 5 ; Ferrari, M.D. 6 ; Bussone, G. 2
1 2 Department of Gynecology and Obstetrics, Women’s Headache Center, University of Torino, Torino, Italy; Department of Clinical
Neurosciences, Carlo Besta National Neurological Institute, Milano, Italy; 3Italian Institute of Telemedicine, Varese, Italy;
4 5 Headache Centre, IRCCS C. Mondino Foundation, Institute of Neurology, Pavia, Italy; Istituto Lusofarmaco d’Italia, Milano, Italy;
6Leiden Centre for Translational Neuroscience, Department of Neurology, Leiden University Medical Centre, Netherlands
P192 Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over,
multicenter Italian study
Bartolini, M. 1 ; Giamberardino, M.A. 2 ; Lisotto, C. 3 ; Martelletti, P. 4 ; Moscato, D. 4 ; Panascia, B. 5 ; Savi, L. 6 ; Pini,
L.A. 7 ; Sances, G. 8 ; Santoro, P. 9 ; Zanchin, G. 10 ; Omboni, S. 11 ; Ferrari, M.D. 12 ; Fierro, B. 13 ; Brighina, F. 13
1 2 Clinica Neurologica, Ospedali Riuniti, Università Politecnica delle Marche, Ancona, Italy; Dipartimento di Medicina e Scienze
dell’Invecchiamento, Università “G. D’Annunzio”, Chieti, Italy; 3Ospedale Civile San Vito al Tagliamento, Pordenone, Italy; 4UOS Cefalea, Ospedale S. Andrea, Università La Sapienza, Roma, Italy; 5Centro Cefalee, A.O. Universitaria Vittorio Emanuele, Catania,
Italy; 6Department of Neurology, University of Torino, Italy; 7Centro Cefalee, Università degli Studi di Modena e Reggio Emilia,
Reggio Emilia, Italy; 8Centro Cefalee, IRCCS Neurologico C. Mondino, Pavia, Italy; 9Clinica Neurologica, Ospedale S. Gerardo,
Monza, Italy; 10Department of Neurology, University of Padova, Italy; 11Italian Institute of Telemedicine, Varese, Italy; 12Leiden Centre for Translational Neuroscience, Department of Neurology, Leiden University Medical Centre, Netherlands; 13Department of
Neurology and Psichiatry, University of Palermo, Palermo, Italy
P193 Occipital Nerve Stimulation (ONS) for the treatment of chronic headache syndromes
Vesper, J. 1 ; Bara, G. 2 ; Kinfe, T.M. 2 ; Schu, S. 2
1 2 Centre of Neuromodulation, Germany; Functional Neurosurgery, Germany
P194 Anodal transcranial direct current stimulation of the visual cortex for migraine prevention:
a proof-of-concept study
Viganò, A. 1 ; Magis, D. 2 ; Sava, S.L. 2 ; De Pasqua, V. 2 ; Auvé, M. 2 ; Giuliani, A. 3 ; Colosimo, A. 1 ; Di Piero, V. 1 ;
Schoenen, J. 2
1 2 3 Sapienza - University of Rome, Italy; ULg - University of Liège, Belgium; Istituto Superiore di Sanità, Italy
P195 Prophylaxis of migraine with aura: a place for acetylsalicylic acid
Savi, L.T. 1 ; Condello, C. 1 ; Bert, F. 2 ; Pinessi, L. 3
1 2 3 Headache Centre, Italy; Department of Public Health, Italy; University of Turin, Italy
P196 Migraine attacks during menses: efficacy of eletriptan and relationship to recurrence after response
Bhambri, Almas, Abdulsattar, Chatterjee,
Pfizer Inc., United States
57